Johnson & Johnson quarterly profit jumps 32%

Johnson & Johnson quarterly profit jumps 32%

Reuters

Published

Johnson & Johnson on Wednesday posted a 32% rise in fourth-quarter profit, boosted by demand for its cancer drugs Darzalex and Imbruvica.

Full Article